AT
About
Allos Therapeutics is a biopharmaceutical company that develops and commercializes anti-cancer therapeutics. FOLOTYN, the company’s main product is a folate analogue metabolic inhibitor design to accumulate preferentially in cancer cells so as to cause cell death. Allos Therapeutics was founded in 1992 and is headquartered in Westminster, Colorado. As of September 4, 2012, Allos Therapeutics operates as a subsidiary of Spectrum Pharmaceuticals, Inc.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 195 investors are based in Berkeley, California, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech biotech
- Location
- Berkeley, US
Contact Information
linkedin.com/in/••••••••
Find more investors like Allos
Search Investors